CytoMed Therapeutics Limited Ordinary Shares Strategic Asset Allocation Index
CytoMed Therapeutics Limited Ordinary Shares strategic asset allocation index. CytoMed Therapeutics Limited Ordinary Shares (GDTC) has a Strategic Asset Allocation Index of 0.3% as of December 2025. Strategic assets (PP&E of $- plus long-term investments of $18.21K) total $18.21K, measured against net assets of $6.85 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See net asset quality index of CytoMed Therapeutics Limited Ordinary Sh to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of CytoMed Therapeutics Limited Ordinary Shares (2019–2025)
Strategic asset allocation index of CytoMed Therapeutics Limited Ordinary Shares from 2019 to 2025. This chart shows how CytoMed Therapeutics Limited Ordinary Shares's Strategic Asset Allocation Index has evolved across 7 annual periods from 2019 to 2025. As of December 2025, the index stands at 0.3%, representing strategic assets of $18.21K against net assets of $6.85 Million USD. Check GDTC goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
CytoMed Therapeutics Limited Ordinary Shares Strategic Asset Allocation Index by Year (2019–2025)
CytoMed Therapeutics Limited Ordinary Shares strategic asset allocation index by year from 2019 to 2025. The table below presents the year-by-year Strategic Asset Allocation Index for CytoMed Therapeutics Limited Ordinary Shares from 2019 to 2025, covering 7 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market value of CytoMed Therapeutics Limited Ordinary Sh.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 0.3% | $18.21K | $- | $18.21K | $6.85 Million | ▼ -2.2 pp |
| 2024 | 2.4% | $220.95K | $- | $220.95K | $9.04 Million | ▲ +0.7 pp |
| 2023 | 1.7% | $195.07K | $- | $195.07K | $11.27 Million | ▼ -459.1 pp |
| 2022 | 460.8% | $2.71 Million | $2.47 Million | $239.42K | $589.03K | ▲ +354.2 pp |
| 2021 | 106.6% | $2.77 Million | $2.50 Million | $272.97K | $2.60 Million | ▼ -376.0 pp |
| 2020 | 482.6% | $2.30 Million | $2.30 Million | $0.00 | $476.83K | ▲ +361.9 pp |
| 2019 | 120.7% | $2.34 Million | $2.34 Million | $- | $1.94 Million | — |